evitria based in Schlieren (Switzerland) is a biotechnology company specialized in protein expression. The company offers custom monoclonal antibodies and comparable molecules as well as gene expression services.
evitria was founded 2010 and has been conducting more than 40,000 transfections. Customers of evitria are typically renowned pharmaceutical and biotechnology companies as well as research institutions. The customers have a constant demand for specific proteins tailored to their respective research purposes; they use evitria as a highly specialized outsourcing partner.
Afinum acquires majority of biotech company evitria, a leading provider of custom antibodies
Dec 20, 2018
Afinum Achte Beteiligungsgesellschaft mbH & Co. KG, advised by Afinum Management GmbH, acts as lead investor und majority owner and jointly invests with SHS V Medtech Investments GmbH & Co. KG and management into evitria AG („evitria“).